Sangamo Therapeutics

www.sangamo.com
501 Canal Blvd.
Richmond, CA 94804

Company Info

Phone
(510) 970-6000

Year Established
1996

Ticker
SGMO

Exchange
NASDAQ

Contacts

Stephanie J. Seiler, CLP
Head of Business Development & Alliance Management

Nathalie Dubois-Stringfellow, Ph.D.
CDO

Sandy Macrae, M.B., Ch.B., Ph.D.
CEO

Prathyusha Duraibabu, CPA, MBA
CFO

Scott Willoughby
General Counsel

Company Description

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.